<div id="readability-page-1">May 19 (Reuters) - Parabilis Medicines on Tuesday filed for an initial public offering in the United States, according to a regulatory filing, and said it intends to use part of the proceeds to support the development of its drug pipeline. The IPO comes as investor appetite for new listings has improved following strong market debuts by companies such as AI chipmaker Cerebras Systems and</div>

CBRS

<p>生物製藥公司 Parabilis Medicines 已在美國提交了首次公開募股（IPO）申請，計劃將部分收益用於開發其藥物管線。這一舉措是在 Cerebras Systems 等公司成功上市後，投資者對新上市公司的興趣重新升温之際進行的</p>

生物製藥公司 Parabilis Medicines 申請在美國進行首次公開募股